TMS for Major Depression: A multisite observational study -2012

TMS for Major Depression PDF

By: Linda L. Carpenter, M.D., Philip G. Janicak, M.D., Scott T. Aaronson, M.D., Terrence Boyadjis, M.D., David G. Brock, M.D., Ian A. Cook, M.D., David L. Dunner, M.D., FACPsych, Karl Lanocha, M.D., H. Brent Solvason, Ph.D., M.D., and Mark A. Demitrack, M.D.

Background: Few studies have examined the effectiveness of transcranial mag- netic stimulation (TMS) in real-world clinical practice settings. Methods: Forty- two US-based clinical TMS practice sites treated 307 outpatients with Major Depressive Disorder (MDD), and persistent symptoms despite antidepressant pharmacotherapy. Treatment was based on the labeled procedures of the approved TMS device. Assessments were performed at baseline, week 2, at the point of maximal acute benefit, and at week 6 when the acute course extended beyond 6 weeks. The primary outcome was change in the Clinician Global Impressions-Severity of Illness from baseline to end of acute phase. Secondary outcomes were change in continuous and categorical outcomes on self-report depression scales (9-Item Patient Health Questionnaire [PHQ-9], and Inventory of Depressive Symptoms-Self Report [IDS-SR]).

Related Posts

rTMS depression
March 13, 2024
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
September 14, 2023
Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depression
September 8, 2023
Effect of repetitive transcranial magnetic stimulation on anxiety symptoms in patients with major depression: An analysis from the THREE‐D trial
September 8, 2023
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after 2 antidepressant treatment failures
September 8, 2023
rTMS and application for OCD
February 15, 2019
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy
February 15, 2019
RANZCP Clinical Practice Guidelines for Mood Disorders
February 15, 2019
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression
February 15, 2019
Repetitive transcranial magnetic stimulation in the treatment of depression
February 15, 2019
TMS Australia. A safety guide for psychiatrists.
May 7, 2018
TMS Social Consensus Review and Treatment for TMS Therapy
May 18, 2016
A multisite, naturalistic, observational study of TMS for patients with pharmacoresistant major depressive disorder – 2014
March 14, 2015
The expanding evidence base for rTMS treatment of depression – 2014
March 6, 2015
TMS for treating depression in elderly patients – 2013
March 6, 2015
Daily Left Prefrontal rTMS in the acute treatment of major depression – 2008
March 6, 2015
Should we expand the toolbox of psychiatric methods to include rTMS? – 2010
March 6, 2015
Efficacy and Safety of TMS in the Acute Treatment of Major Depression – 2007
March 6, 2015
Comparing the Effects of rTMS and ECT in the Treatment of Depression – 2014
March 3, 2015
TMS: Summary of Safety Experience from Acute Exposure – 2008
March 3, 2015